Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control studyNichola Johnson, Alfons Meindl, Frank Dudbridge et al.|Breast Cancer Research|2014Cited by 46
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trialReinier C A van Linschoten, Aura A. J. van Esch, Fenna M. Jansen et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 21
Laboratory variation in the grading of dysplasia of duodenal adenomas in familial adenomatous polyposis patientsElsa Soons, Femke Atsma, Peter D. Siersema et al.|Familial Cancer|2022Cited by 2
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn’s Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI TrialReinier C A van Linschoten, Fenna M. Jansen, R Pauwels et al.|Digestive Diseases and Sciences|2024Cited by 2
The effectiveness of adding braun anastomosis to standard child reconstruction to reduce delayed gastric emptying after pancreatoduodenectomy: protocol for a multicenter randomized-controlled trial (REMBRANDT) by the Dutch Pancreatic Cancer GroupBo T M Strijbos, Martijn W.J. Stommel, Jana S. Hopstaken et al.|HPB|2024Cited by 0